Back to BlackRock, Inc. BlackRock, Inc.

DMACDMAC
7 quarters

Position history for BlackRock, Inc.BlackRock, Inc.'s holdings in DIAMEDICA THERAPEUTICS INC

BlackRock, Inc. holds 2.3M shares of DMAC (DIAMEDICA THERAPEUTICS INC), worth $15.9M as of 2026-Q2. The position was increased (+21.3% shares). DMAC represents 0.0% of BlackRock, Inc.'s portfolio.

Current Value

$15.9M

Current Shares

2.3M

Total Value Change

+$15.3M

Total Shares Change

+2.1M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
2.3M
+21.3%
$15.9M0.0%$7.04
34
2026-Q1
Decreased
1.9M
-2.4%
$12.6M0.0%$7.71
0
2025-Q4
Increased
1.9M
+13.3%
$15.1M0.0%$8.05
32
2025-Q3
Increased
1.7M
+40.8%
$11.5M0.0%$6.91
37
2025-Q2
Increased
1.2M
+1020.6%
$4.6M0.0%$3.84
43
2025-Q1
Decreased
106,350
-1.4%
$403,0660.0%$3.82
0
2024-Q4
New
107,880
-
$585,7890.0%$5.34
37

Other major holders of DMAC: COOPERMAN LEON G

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used